SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: RXGOLF who wrote (25871)9/29/1998 9:23:00 PM
From: Henry Niman  Respond to of 32384
 
Greg, I think that today's announcement was to secure cash for the development of ONTAK and Panretin. I would think that a buyout would be several years in the future, and that the likelihood of such a deal would be dependent on how the new drugs sell. LGND anticipates $200-300 million in sales by 2001 with a profit margin of 40%. If they hit those numbers (or even come close), I would expect them to stay independent.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News